CRF Health, which provides electronic Clinical Outcome Assessment (eCOA) solutions for the life sciences industry, is teaming-up with Vodafone to use their global Machine-to-Machine (M2M) platform and offer an enhanced service to clinical trial operators and their patients.
As a result of the partnership, managing mobile data sending in clinical studies using the TrialMax eCOA platform is made easier and more predictable for CRF Health clients. The agreement provides clinical trial sponsors running global studies with assured connectivity and instant access to data through Vodafone’s global network. Reliability, security and integration are crucial to ensure that healthcare industry requirements and standards are met.
“Partnering with Vodafone will help us provide our clients with more predictable data sending while improving the quality of our products and services,” said CRF Health’s Vice President of Contracts and Vendor Management, Jaime Racine.